ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Outsourcing

CordenPharma expands peptide capacity

by Rick Mullin
July 11, 2020 | APPEARED IN VOLUME 98, ISSUE 27

 

09827-buscon14-corden.jpg
Credit: CordenPharma
New peptide production equipment at CordenPharma

CordenPharma, a German contract development and manufacturing organization, has completed a 3,000 L expansion of its solid-phase peptide plant in Boulder, Colorado, bringing capacity at the site to 13,000 L. The new capacity allows the firm to manufacture 400 kg of a complex, long peptide per single batch, according to Matthieu Giraud, the firm’s director of peptide, lipid, and carbohydrate operations. The site also features a 100 cm high-pressure reverse-phase purification column.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment